Authors


Danielle Mroz, MA

Latest:

SVR Possible in PWID Infected With Hepatitis C Virus Despite Imperfect Adherence to Treatment

People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.


Eileen Oldfield

Latest:

Hepatitis C Saliva Tests May Show a False-Negative Result if HIV Is Also Present

Saliva tests for detecting HCV infection may not be the best option for determining infection status.


Gary L. Edwards, MS

Latest:

Utah's Public Health Approach to Recent Hepatitis A Outbreak

In May 2017, a case of hepatitis A was detected in a Salt Lake County hospital. Over the next 20 months, Utah health officials worked to address what ended up being the largest hepatitis A outbreak in the state’s history.



SANDRA MORALES, PHD

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


Della Xu, PharmD

Latest:

How Close Are We to a Cure for HIV?

Evolving research has led the infectious diseases community to redefine its definition of cure.


JAMES ROSSI, MD

Latest:

Salt, Ticks, and Lyme: A Case of Lyme Neuroborreliosis Presenting as SIADH

This case report is the fourth documented case of Lyme-induced syndrome of inappro­priate secretion of antidiuretic hormone (SIADH).



SASKIA V. POPESCU, PhD, MPH, MA, CIC

Latest:

Examining COVID-19 Mortality Rates Against Specific Treatments for Inpatients

A recent study examined mortality outcomes in hospitalized COVID-19 patients treated with remdesivir and dexamethasone vs dexamethasone alone, using data from the Omicron period.


Kevin Schwartz, MD, MSc, FRCPC

Latest:

"Antibiotic Never Events": The Ideal Target to Reduce Antimicrobial Exposure

By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.


Sarah M. Michienzi, PharmD

Latest:

Antiretroviral Stewardship: The Time is Now

In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.


Pharmacy Times&reg Editorial Staff

Latest:

National HIV Testing Day: Free Screening Services Available at Walgreens

Testing and information will be available at select Walgreens stores in more than 260 cities on National HIV Testing Day on Thursday between 10 am and 7 pm.



Cecilia Pessoa Gingerich

Latest:

E-cigarette Users, Especially Women, May Be More Susceptible to Flu

Early research found that e-cigarette use affects the immune system response to the flu virus and the effects are different for female and male users.


ALYSSA B. CHRISTENSEN, PHARMD

Latest:

Is Greater BSA Use for Sepsis, Bacteremia Affecting HO-CDIs?

An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.


Jennifer Lo, PharmD

Latest:

"Antibiotic Never Events": The Ideal Target to Reduce Antimicrobial Exposure

By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.


Stephanie Spivack, MD

Latest:

A Case of Varicella-Zoster Meningitis Causing Postoperative Fevers After Umbilical Hernia Repair

Due to worsening headaches and unrevealing cross-sectional imaging and ascites fluid analyses, this patient's differential evolved toward a central nervous system source.


AMY CHENG, PHARMD, AAHIVP

Latest:

Treating HCV in HIV-Coinfection: Still a Therapeutic Dilemma?

Despite the availability of highly active agents against HCV, HIV-infected patients require special considerations for drug interactions when considering treatment options.


Caitlyn Bahrenburg

Latest:

Site-Specific Labeling Provides New Insight on Influenza Virus Variation

A new method assessing the influenza A strain provides investigators with a more detailed look at influenza viruses.


Tiffany Lee, PharmD, BCIDP

Latest:

Febrile Finesse: Are We Employing Appropriate Empiric Coverage in Patients With Neutropenic Fever?

Traditional therapy coverage does not include recent data that offers some updates in evaluating the current effectiveness of empiric antibiotic treatment.


Gena M. Burch, PharmD, MS

Latest:

Individualized Beta-Lactam Therapy and Monitoring

Elevated beta-lactam concentrations have been associated with neurotoxic adverse effects, including seizures and mental status changes.


Bryan T. Alexander, PharmD, BCIDP, AAHIVP

Latest:

A Chance to Improve Hepatitis C Care for PWID

Here is a review of an opportunistic treatment approach to HCV infection in this patient population in a European study and some of the potential challenges in applying it in the United States.


Whitney J. Palmer

Latest:

Those With HIV Shown to Have More Coronary Plaque

Even if HIV-positive individuals have a low-to-moderate risk for cardiovascular disease, they still experience more coronary plaque.



Syra Madad, DHSC, MSC; and Vikram Mukherjee, MD

Latest:

10 Key Pillars to an Effective Ebola Response

EVD outbreaks this year serve as a reminder of the virus’ severity and the importance of having a containment strategy in place.


Kristin L. Feick, PHARMD, BCPS

Latest:

Oral Therapeutic Options to Prevent Disease Progression From COVID-19 in an Ambulatory Setting

As the number of COVID-19 cases continues to rise, oral treatment options for at-home use are in demand to provide early intervention and reduce the progression to severe disease, hospitalization, and death.


Alba Azola, MD

Latest:

Navigating Long COVID and ME/CFS Overlap

Alba Azola, MD discusses the challenges of diagnosing and managing Long COVID and its overlap with ME/CFS, emphasizing the need for individualized care and ongoing research.


Michael Trisler, PharmD, MPH, BCIDP

Latest:

Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?

Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.


Catherine Bertrand Ferrandis, DVM

Latest:

Combating Misinformation on Antimicrobials

Insights from Catherine Bertrand Ferrandis, DVM, on the role of One Health and interdisciplinary collaboration.


© 2025 MJH Life Sciences

All rights reserved.